Clinical trial Recruiting at 1 site Observational Ages Any age to 99

Keikku electronic stethoscope for recording heart sounds and detecting murmurs and wheezing

Official title: Prospective, Controlled, Open-label Study Evaluating the Keikku Electronic Stethoscope

Run by Lapsi Health Holding B.V. · NCT07044128 · Data updated 2026-11-12

We will test whether the Keikku electronic stethoscope can accurately record heart sounds and help doctors detect heart murmurs and wheezing in people of all ages during routine, non-urgent heart checks.

More Wheezing trials

Quick facts

Study typeObservational
AgesAny age to 99 Years
SexAll
Enrollment149 (estimated)
SponsorLapsi Health Holding B.V.
Industry-sponsored
Locations1 site (Lima)
StatusRecruiting
StartedJuly 15, 2025
Main results expectedSeptember 15, 2025
Study endsOctober 15, 2025
Registry record updatedJune 29, 2025
Trial IDNCT07044128 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People from birth through age 99 who are undergoing non-urgent outpatient or inpatient cardiac evaluation or cardiac clearance for a suspected or known murmur are the intended participants; pregnant individuals are excluded.

Probably not a fit

Patients with urgent or emergency cardiac conditions and pregnant individuals are not eligible and are unlikely to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, open-label, controlled investigation will enroll 149 participants from newborns through age 99 at a single site in Lima, Peru. Each participant will have sequential auscultation at four standard precordial locations using the Keikku electronic stethoscope (with Bluetooth headphones) and a conventional stethoscope performed by a second, blinded physician. Physicians will independently record whether a murmur is present and rate acoustic quality on a 5-point Likert scale, while researchers monitor for device issues or adverse events. The study compares the diagnostic findings between the digital device and standard analog auscultation without automated interpretation of recordings.

Why it matters

Potential benefit: If successful, the device could allow clinicians to reliably record and share high-quality heart sounds for diagnosis and remote review, which may improve detection and follow-up of murmurs.

How similar studies have gone: Prior studies of electronic/digital stethoscopes have frequently shown comparable murmur detection to analog stethoscopes, but results depend on device design and setting, so direct evidence for this specific device is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric, including newborn (from birth to 1 month of age), or adult (aged 99 or below) individuals.
* Individuals who are either:

  * presenting for initial, non-urgent outpatient evaluation of a cardiac murmur or for non-urgent cardiac clearance; or
  * presenting for return, non-urgent outpatient evaluation of a cardiac murmur; or
  * undergoing initial or recurrent, non-urgent evaluation of a cardiac murmur in inpatient setting; or
  * undergoing non-urgent cardiac clearance in inpatient setting.

Exclusion Criteria:

pregnant female individuals

Where it's running

  • Clinica Internacional San Borja
    Lima, Peru
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.